Apoptosis in cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (169)
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
1972 • 15,349 citations
Mitochondria and Apoptosis
1998 • 8,909 citations
Cell Death: The Significance of Apoptosis
1980 • 7,281 citations
Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade
1997 • 7,177 citations
Caspases: Enemies Within
1998 • 6,923 citations
Apoptosis in the Pathogenesis and Treatment of Disease
1995 • 6,610 citations
Death Receptors: Signaling and Modulation
1998 • 5,873 citations
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 • 4,870 citations
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
1998 • 4,383 citations
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
1995 • 4,043 citations
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
1990 • 3,817 citations
Integrin Signaling
1999 • 3,705 citations
BCL-2 family members and the mitochondria in apoptosis
1999 • 3,657 citations
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
1988 • 3,194 citations
Disruption of epithelial cell-matrix interactions induces apoptosis
1994 • 3,167 citations
Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3
1997 • 3,130 citations
Regulation of Cell Death Protease Caspase-9 by Phosphorylation
1998 • 3,129 citations
Induction of apoptosis in fibroblasts by c-myc protein
1992 • 2,977 citations
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 • 2,969 citations
p53 is required for radiation-induced apoptosis in mouse thymocytes
1993 • 2,911 citations
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
1996 • 2,665 citations
Social controls on cell survival and cell death
1992 • 2,641 citations
A model for p53-induced apoptosis
1997 • 2,502 citations
Thymocyte apoptosis induced by p53-dependent and independent pathways
1993 • 2,322 citations
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
1996 • 2,304 citations
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
1997 • 2,245 citations
Apoptosis. Its significance in cancer and cancer Therapy
1994 • 2,148 citations
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
1991 • 2,127 citations
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
1999 • 1,972 citations
Involvement of the bcl -2 Gene in Human Follicular Lymphoma
1985 • 1,797 citations
Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome Translocation
1984 • 1,761 citations
Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
1997 • 1,694 citations
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
1999 • 1,650 citations
Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9
1998 • 1,642 citations
A Matter of Life and Cell Death
1998 • 1,523 citations
Bax directly induces release of cytochrome c from isolated mitochondria
1998 • 1,514 citations
An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL
1997 • 1,506 citations
Sunburn and p53 in the onset of skin cancer
1994 • 1,501 citations
p53 Status and the Efficacy of Cancer Therapy in Vivo
1994 • 1,483 citations
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death
1996 • 1,456 citations
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
1999 • 1,447 citations
Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype
1997 • 1,329 citations
Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo
1998 • 1,292 citations
bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
1989 • 1,252 citations
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
1998 • 1,248 citations
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
1999 • 1,248 citations
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
1998 • 1,180 citations
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB
1997 • 1,162 citations
Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
1998 • 1,143 citations
Autoactivation of Procaspase-9 by Apaf-1-Mediated Oligomerization
1998 • 1,132 citations
p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
1999 • 1,076 citations
Bcl-2 family proteins
1998 • 1,055 citations
Disruption of p53 in human cancer cells alters the responses to therapeutic agents
1999 • 1,044 citations
An Induced Proximity Model for Caspase-8 Activation
1998 • 1,030 citations
Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
1999 • 1,001 citations
Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells
1996 • 1,001 citations
Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
1999 • 999 citations
Apoptotic cell death induced by c-myc is inhibited by bcl-2
1992 • 981 citations
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
1999 • 969 citations
Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
1989 • 937 citations
BID: a novel BH3 domain-only death agonist.
1996 • 921 citations
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
1998 • 912 citations
BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases
1996 • 911 citations
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
1990 • 910 citations
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
1993 • 898 citations
Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian Development
1998 • 894 citations
FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis
1998 • 893 citations
p53-Dependent apoptosis suppresses tumor growth and progression in vivo
1994 • 883 citations
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
1993 • 875 citations
p53 and E2F-1 cooperate to mediate apoptosis.
1994 • 844 citations
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
1998 • 843 citations
Senescence of human fibroblasts induced by oncogenic Raf
1998 • 805 citations
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
1994 • 772 citations
Cooperative interaction between c-myc and bcl-2 proto-oncogenes
1992 • 766 citations
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
1994 • 747 citations
Inactivation of Bcl-2 by phosphorylation.
1995 • 744 citations
Mediation of c-Myc-Induced Apoptosis by p53
1994 • 741 citations
Tumor surveillance via the ARF–p53 pathway
1998 • 735 citations
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
1999 • 708 citations
Role of Bcl‐2 family proteins in apoptosis: apoptosomes or mitochondria?
1998 • 705 citations
PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond
1997 • 699 citations
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.
1993 • 677 citations
DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2
1994 • 671 citations
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.
1992 • 665 citations
Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
1999 • 663 citations
Bax suppresses tumorigenesis and stimulates apoptosis in vivo
1997 • 648 citations
Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type II
1999 • 631 citations
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
1994 • 617 citations
E1A signaling to p53 involves the p19ARFtumor suppressor
1998 • 614 citations
PTEN: a tumour suppressor that functions as a phospholipid phosphatase
1999 • 592 citations
The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice.
1994 • 564 citations
Inhibition of Ced-3/ICE-related Proteases Does Not Prevent Cell Death Induced by Oncogenes, DNA Damage, or the Bcl-2 Homologue Bak
1997 • 555 citations
A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.
1996 • 544 citations
Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
1994 • 538 citations
A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.
1999 • 536 citations
Bcl-X L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation
1998 • 534 citations
Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis.
1994 • 515 citations
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
1999 • 492 citations
Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene.
1994 • 465 citations
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
1999 • 455 citations
Drug-target interactions: only the first step in the commitment to a programmed cell death?
1991 • 412 citations
Activation of programmed cell death by anticancer agents: cisplatin as a model system.
1990 • 408 citations
Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
1994 • 406 citations
Cell-cycle arrest versus cell death in cancer therapy
1997 • 394 citations
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
1993 • 392 citations
A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis
1994 • 391 citations
Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs
1999 • 380 citations
bax -deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis
1997 • 371 citations
Cellular senescence and cancer
1999 • 363 citations
Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint
1995 • 361 citations
c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release
1999 • 330 citations
Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system.
1996 • 325 citations
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
1999 • 312 citations
Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53.
1994 • 310 citations
Anatomy of TRAF2
1996 • 302 citations
An electron‐microscope study of the mode of cell death induced by cancer‐chemotherapeutic agents in populations of proliferating normal and neoplastic cells
1975 • 300 citations
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
1996 • 299 citations
Systemic Overexpression of BCL-2 in the Hematopoietic System Protects Transgenic Mice From the Consequences of Lethal Irradiation
1998 • 299 citations
Apoptosis and therapy
1999 • 294 citations
Hematopoietic Malignancies Demonstrate Loss-of-Function Mutations ofBAX
1998 • 291 citations
Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.
1994 • 290 citations
A Mutant p53 That Discriminates between p53-Responsive Genes Cannot Induce Apoptosis
1996 • 283 citations
Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells.
1993 • 280 citations
Essential Role of CED-4 Oligomerization in CED-3 Activation and Apoptosis
1998 • 269 citations
p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation.
1994 • 264 citations
A single chicken anemia virus protein induces apoptosis
1994 • 255 citations
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
1993 • 238 citations
Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells
1997 • 234 citations
Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype.
1999 • 233 citations
Clinical implications of p53 mutations
1999 • 230 citations
atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity
1997 • 227 citations
The role of p53 in tumour suppression: lessons from mouse models
1999 • 202 citations
Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis.
1995 • 200 citations
Oncogene-dependent apoptosis is mediated by caspase-9
1998 • 174 citations
A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis
1998 • 173 citations
Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice
1997 • 159 citations
Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA
1984 • 156 citations
Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations.
1995 • 138 citations
p53-mediated apoptosis in HeLa cells can be overcome by excess pRB.
1995 • 136 citations
A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells.
1995 • 134 citations
Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage
1999 • 125 citations
The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia.
1998 • 123 citations
Association of Chromosome Arm 9p Abnormalities With Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Cancer Group
1999 • 107 citations
Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins
1997 • 103 citations
Transformation by human adenoviruses
1984 • 98 citations
In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
1999 • 95 citations
Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy.
1998 • 87 citations
In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
1996 • 86 citations
bcl-xs gene therapy induces apoptosis of human mammary tumors in nude mice.
1996 • 82 citations
p53 modulation of anchorage independent growth and experimental metastasis.
1996 • 80 citations
Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins
1987 • 74 citations
Oncogene-dependent apoptosis in extracts from drug-resistant cells.
1997 • 65 citations
Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers
1998 • 63 citations
Characterization of the Mouse Cyclin D3 Gene: Exon/Intron Organization and Promoter Activity
1996 • 62 citations
Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
1997 • 60 citations
Adenovirus genes that modulate the sensitivity of virus‐infected cells to lysis by TNF
1993 • 56 citations
Inhibitors of cyclin-dependent kinase and cancer
1995 • 55 citations
Therapeutic intervention and signaling
1998 • 55 citations
Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors.
1998 • 53 citations
c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells
1997 • 44 citations
Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
1996 • 38 citations
The effect of Bcl-2 on Apoptin in 'normal' vs transformed human cells
1999 • 37 citations
Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells
1999 • 34 citations
Apoptin® specifically causes apoptosis in tumor cells and after UV-treatment in untransformed cells from cancer-prone individuals: A review
1998 • 29 citations
bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer
1998 • 25 citations
Myc-Mediated Apoptosis
1996 • 15 citations
Does "death receptor" signaling play a role in tumorigenesis and cancer therapy?
1998 • 14 citations
Die Rolle von CD95 (APO-1/Fas)-Mutationen bei lymphoproliferativen und malignen lymphatischen Erkrankungen
1998 • 10 citations
Apoptosis in Leukemia Cells
1996 • 4 citations